CARTESIAN THERAPEUTICS INC (RNAC) Stock Earnings Estimates

USA Nasdaq NASDAQ:RNAC • US8162123025

6.79 USD
-0.04 (-0.59%)
At close: Feb 2, 2026
6.79 USD
0 (0%)
After Hours: 2/2/2026, 4:30:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RNAC revenue by date.RNAC revenue by date.
110.777M
30.21%
26.004M
-76.53%
38.913M
49.64%
2.006M
-94.84%
600.27K
-70.08%
756.432K
26.02%
24.584M
3,149.99%
92.291M
275.41%
205.29M
122.44%
460.58M
124.36%
716.27M
55.51%
937.94M
30.95%
EBITDA
YoY % growth
RNAC ebitda by date.RNAC ebitda by date.
15.825M
573.09%
-84.873M
-636.32%
-35.167M
58.57%
N/AN/A-169.32M-184.62M
-9.04%
-96.9M
47.51%
-34.68M
64.21%
35.7M
202.94%
N/AN/A
EBIT
YoY % growth
RNAC ebit by date.RNAC ebit by date.
14.538M
416.25%
-85.716M
-689.60%
-36.318M
57.63%
-89.907M
-147.55%
-107.317M
-19.36%
-132.83M
-23.77%
-146.046M
-9.95%
-121.617M
16.73%
-52.895M
56.51%
87.21M
264.87%
206.04M
136.26%
274.75M
33.35%
Operating Margin
RNAC operating margin by date.RNAC operating margin by date.
13.12%-329.63%-93.33%-4,481.90%-17,878.13%-17,560.12%-594.07%-131.78%-25.77%18.93%28.77%29.29%
EPS
YoY % growth
RNAC eps by date.RNAC eps by date.
8.40
190.32%
-10.20
-221.43%
-11.68
-14.51%
-2.39
79.52%
-3.44
-43.74%
-3.83
-11.30%
-2.73
28.58%
-2.81
-2.61%
-2.63
6.18%
2.60
198.84%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.87
-47.53%
-0.87
-28.00%
-0.86
-271.02%
-0.87
36.93%
-0.94
-8.53%
-0.74
15.04%
-0.67
21.87%
-0.67
22.89%
-0.70
26.36%
Revenue
Q2Q % growth
96.563K
25.41%
143.208K
-86.98%
143.208K
-51.94%
143.208K
-68.32%
143.208K
48.30%
461.04K
221.94%
461.04K
221.94%
461.04K
221.94%
461.04K
221.94%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-24M
-25.31%
-25.561M
-16.78%
-26.438M
-21.22%
-27.367M
-29.91%
-29.662M
-23.59%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.38
-22.12%
-0.86-0.52-60.11%
Q2 2025
Q2Q % growth
0.50
-7.41%
-0.831.33160.52%
Q1 2025
Q2Q % growth
-0.68
93.52%
-0.720.045.53%
Q4 2024
Q2Q % growth
-0.59
71.90%
-0.820.2327.70%
Q3 2024
Q2Q % growth
-1.13
37.22%
-0.93-0.20-21.74%
Q2 2024
Q2Q % growth
0.54
125.71%
-1.151.69146.91%
Q1 2024
Q2Q % growth
-10.50
-150.00%
-0.90-9.60-1,063.18%
Q4 2023
Q2Q % growth
-2.10
-275.00%
-1.07-1.03-96.08%
Q3 2023
Q2Q % growth
-1.80
-20.00%
-1.78-0.02-0.85%
Q2 2023
Q2Q % growth
-2.10
-216.67%
-2.450.3514.22%
Q1 2023
Q2Q % growth
-4.20
-160.87%
-2.67-1.53-57.51%
Q4 2022
Q2Q % growth
1.20
33.33%
-2.233.43153.82%
Q3 2022
Q2Q % growth
-1.50
68.75%
-0.17-1.33-758.49%
Q2 2022
Q2Q % growth
1.80
50.00%
-2.364.16176.26%
Q1 2022
Q2Q % growth
6.90
204.55%
-3.3110.21308.15%
Q4 2021
Q2Q % growth
0.90
121.43%
-2.233.13140.37%
Q3 2021
Q2Q % growth
-4.80
-77.78%
-2.27-2.53-111.15%
Q2 2021
Q2Q % growth
1.20
116.00%
-3.584.78133.48%
Q1 2021
Q2Q % growth
-6.60
-4.76%
-3.73-2.87-76.79%
Q4 2020
Q2Q % growth
-4.20 -3.54-0.66-18.62%
Q3 2020
Q2Q % growth
-2.70 1.84-4.54-247.06%
Q2 2020
Q2Q % growth
-7.50 -0.23-7.27-3,167.97%
Q1 2020
Q2Q % growth
-6.30 -8.562.2626.40%
RNAC Yearly EPS VS EstimatesRNAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60 -80 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
452K
16.80%
248.37K203.63K81.99%
Q2 2025
Q2Q % growth
298K
-99.11%
828.75K-530.75K-64.04%
Q1 2025
Q2Q % growth
1.1M
-81.16%
801.424K298.576K37.26%
Q4 2024
Q2Q % growth
77K
-99.07%
105.825K-28.825K-27.24%
Q3 2024
Q2Q % growth
387K
-94.09%
2.331M-1.944M-83.40%
Q2 2024
Q2Q % growth
33.445M
537.17%
2.521M30.924M1,226.66%
Q1 2024
Q2Q % growth
5.84M
-1.65%
1.275M4.565M358.04%
Q4 2023
Q2Q % growth
8.266M
-50.78%
5.993M2.273M37.93%
Q3 2023
Q2Q % growth
6.551M
-68.37%
12.837M-6.286M-48.97%
Q2 2023
Q2Q % growth
5.249M
-86.63%
11.314M-6.065M-53.61%
Q1 2023
Q2Q % growth
5.938M
-82.53%
12.07M-6.132M-50.80%
Q4 2022
Q2Q % growth
16.795M
-43.90%
11.918M4.877M40.92%
Q3 2022
Q2Q % growth
20.71M
-15.22%
25.719M-5.009M-19.48%
Q2 2022
Q2Q % growth
39.273M
99.73%
14.057M25.216M179.38%
Q1 2022
Q2Q % growth
33.999M
207.68%
13.378M20.621M154.14%
Q4 2021
Q2Q % growth
29.937M
150.50%
17.936M12.001M66.91%
Q3 2021
Q2Q % growth
24.427M
425.76%
12.431M11.996M96.50%
Q2 2021
Q2Q % growth
19.663M 7.273M12.39M170.36%
Q1 2021
Q2Q % growth
11.05M 7.672M3.378M44.03%
Q4 2020
Q2Q % growth
11.951M 5.571M6.38M114.52%
Q3 2020
Q2Q % growth
4.646M 21.356M-16.71M-78.24%
Q2 2020
Q2Q % growth
19.125M-19.125M-100.00%
RNAC Yearly Revenue VS EstimatesRNAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 18.02% 0% -16.95%
Revenue0% -75.15% 0% 7.33%